Cancer Drug Copiktra Linked To Increased Risk of Death, FDA Warns
The FDA warns the cancer drug, Copiktra, may be linked to an increased risk of death among patients.
The FDA warns the cancer drug, Copiktra, may be linked to an increased risk of death among patients.
The FDA will hold a hearing later this year to determine whether Makena should be removed from the market because the pregnancy drug's risks appear to outweigh its benefits.
Public Citizen is calling for investigations into an epilepsy seizure trial which it says put patients at risk due to a lack of including proper standards of care.
A new study finds Prozac after a stroke increases the risk of bone fractures, falls and seizures, and does not appear to provide neurological benefits.
The WHO has temporarily halted a clinical trial looking into whether hydroxychloroquine could be used as a COVID-19 treatment after preliminary data suggested its use carried an increased risk of…
A new case study highlights the risk of transferring drug-resistant infections between fecal transplant donors and recipients.
An FDA Advisory board says the pregnancy drug Makena should be pulled from the market after clinical trials indicated it failed to be effective at preventing premature births.
Public Citizen is calling on the FDA to require a Makena recall after the drug failed to show it was effective in preventing preterm births in a recent clinical trial.
A California woman says she was enrolled in a breast implant study without being told the full risks of cancer, leading to her eventually receiving Allergan breast implants and a…
The FDA warns that clinical trials indicate Venclexta can increase the risk of death when given off-label to patients for the treatment of multiple myeloma.